Wednesday, February 11, 2026
ADVT 
International

Starting Jan, 20k H-1B holders will be able to renew their visas in US

Darpan News Desk IANS, 29 Nov, 2023 03:13 PM
  • Starting Jan, 20k H-1B holders will be able to renew their visas in US

New York, Nov 29 (IANS) In a move likely to benefit Indian professionals, 20,000 H1B specialty occupation workers will be able to renew their visas in the US beginning from January next year, according to State Department officials.

This development comes months after the White House announced a pilot programme for domestic renewal of certain categories of H-1B visas during the state visit of Prime Minister Narendra Modi in June this year.

The visa renewal pilot programme is one of multiple measures the State Department is looking to add or continue with the aim of driving down wait times for travel to the US, Bloomberg Law reported, citing officials.

It would allow H-1B holders to renew their visas by mailing them to the State Department rather than travel outside the US and face uncertain wait times to secure an appointment at a US consular office before returning.

“We really need to get proof of concept that it works before we can extend it to a larger group,” Deputy Assistant Secretary for Consular Affairs Julie Stufft told reporters on Monday.

“This is a huge change for folks who live here and previously would have had to leave the US,” she added.

Due to heavy visa backlogs, some H-1B workers have pursued work-arounds such as traveling to nearby countries with fewer backlogs to secure appointments.

According to Stufft, the domestic renewal option would help consular offices in those countries as well as India.

The average wait time to secure a visa appointment for travel to the US fell to 130 days last year, a drop of 70 days from fiscal year 2022.

The State Department considers acceptable wait times to be closer to 90 days.

MORE International ARTICLES

African scientists baffled by monkeypox cases in Europe, US

African scientists baffled by monkeypox cases in Europe, US
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. 

African scientists baffled by monkeypox cases in Europe, US

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk